The drug - in the form of its Mounjaro KwikPen device - was approved by the UK's ... Back in June, the Society for Acute Medicine warned that doctors were treating "increasing numbers" of patients ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

In the case of Ms Susan McGowan’s death, it is believed to be the first time the drug tirzepatide, known under the brand name ...

An influencer, known as Heather, has organised a party celebrating weight loss jab tirzepatide, close to where NHS worker ...

It is thought to be the first time the medicine has been listed as a contributing factor on a death certificate. Like all drugs, Mounjaro is not without side-effects. Yet speaking to MailOnline ...

Mounjaro was approved based on extensive assessment of the benefits and risks of the medicine, and we provide information ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Has something changed regarding Eli Lilly or Regeneron's thesis, or is the recent dip an excellent opportunity to invest in ...

They previously said patient safety was a priority and added: “Mounjaro was approved based on extensive assessment of the ...

A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.